Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
Anna Metcalfe, RAC Vice President, Regulatory Affairs
Anna Metcalfe, the Regulatory Affairs Vice President of the Pharmaceutical & Healthcare Group at Intertek Scientific & Regulatory Consultancy (formerly Cantox), oversees regulatory staff in the planning, organization, and co-ordination of nonclinical, clinical, and regulatory submission activities. Her primary responsibility is to provide strategic and operational regulatory expertise and leadership necessary to advance the nonclinical and clinical development of drug products from Phase I to Phase III worldwide, for many clients.
With over 25 years experience in various therapeutic areas in International Regulatory Affairs, she has developed skills in Clinical Research, Project Management, Drug Development, Medical Information and Medical Research. Anna Metcalfe has successfully acted as Project Leader for the development of a number of drug candidates from the nonclinical stage to marketing authorizations in the US, Canada, and EU.
Ms. Metcalfe received an Honours Bachelor of Science degree with a specialty in Pharmacology from the University College London, England and has several publications in the area of regulatory and clinical affairs.
Need help or have a question?